Article
Treprostinil in the treatment of pediatric patients with severe Idiopathic and Heritable Pulmonary Arterial Hypertension
2023-03-22
Abstract excerpt
<h4>Introduction: </h4> Data have been accumulating that parental treprostinil is safe and effective in pediatric PAH patients. This study was designed to evaluate the efficacy of treprostinil in severe pediatric patients with IPAH and HPAH (IPAH/HPAH). <h4>Methods:</h4> Children diagnosed with IPAH/HPAH between August 2018 to April 2022 treated with treprostinil at a single center were included in this study. Cli...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c80bfcd7-fc2d-591b-80bf-69781da217c2
- DOI
- 10.21203/rs.3.rs-2664529/v1
